Renseignements pour les professionnels de la santé

COVID-19 Vaccine: Updated Interval for Booster Doses and Expanded Eligibility for Second Booster Doses (PDF, en anglais seulement)

Manitoba COVID-19 Vaccine: Novavax, 12-17 year old and 18+ First Boosters (PDF, en anglais seulement)

Manitoba COVID-19 Vaccine: Second Booster Recommendations and Moderna for 6-11 years of age (PDF, en anglais seulement)

COVID-19 Vaccine: mRNA vaccine supply update and updated interchangeability guidance for individuals aged ≥ 30 years (PDF, en anglais seulement)

COVID-19 Vaccine: Booster Dose Guidance for Adolescents (PDF, en anglais seulement)

COVID-19 Vaccine: Clarifying Recommended and Minimum Intervals (PDF, en anglais seulement)

COVID-19 Vaccine: Moderna for individuals aged ≥ 30 years (PDF, en anglais seulement)

COVID-19 Vaccine: updated third/booster dose interval for individuals aged ≥ 50 years and updated vaccine product for individuals aged ≥ 30 years(PDF, en anglais seulement)

COVID-19 Vaccine: updated third/booster dose guidance and preferential use of Pfizer/Comirnaty^TM for 12 to 29 year olds (PDF, en anglais seulement)

COVID-19 Vaccine: Approval/Guidance for Children aged five to ≤ 11 years (PDF, en anglais seulement)

COVID-19 Vaccine Update: Pharmacists to Start Administering COVID-19 and Influenza Vaccines to Those Five Years of Age and Older (PDF, en anglais seulement)

COVID-19 Vaccine Update: Expanded Third/ Booster Dose 6 Months After Dose 2 Guidance (PDF, en anglais seulement)

COVID-19 Vaccine: Third/Booster Dose Update (PDF, en anglais seulement)

COVID-19 Vaccine RE: Important Program Updates (PDF, en anglais seulement)

COVID-19 Vaccine: Booster/Third Dose Guidance and Expansion to Include Residents of Congregate Elderly Person Housing Sites (PDF, en anglais seulement)

Moderna/Spikevax - Prolongation de 2 mois de la durée de vie (pdf)

COVID-19 Vaccine Medical Exemption Program (PDF, en anglais seulement)

COVID-19 Vaccine: Expansion of Third Doses to Health Care Personnel and to People who received a Viral Vector Vaccine Series (PDF, en anglais seulement)

Manitoba Adopting National Advisory Committee on Immunization (NACI) Guidance (PDF, en anglais seulement)

COVID-19 Vaccine Guidance for Personal Care Homes: Recommended Interval between Second and Third Doses of COVID-19 Vaccine & Update on COVID-19/Flu Vaccine Sequence of Administration(PDF, en anglais seulement)

COVID-19 Vaccine: Additional mRNA Vaccine Dose for Certain Populations and Medical Exemption Program (PDF, en anglais seulement)

COVID-19 Vaccine Guidance for Personal Care Homes: Recommended Interval between Second and Third Doses of COVID-19 Vaccine & Update on COVID-19/Flu Vaccine Sequence of Administration (PDF, en anglais seulement)

COVID-19 Vaccine: Expansion of Third Doses to Personal Care Homes (PDF, en anglais seulement)

COVID-19 Vaccine: Additional Information on Third Doses (PDF, en anglais seulement)

Pfizer - élargissement des conditions approuvées de conservation à ultra-basse température (pdf)

COVID-19 Vaccine: UPDATE - Allergy Assessment and Referral Update (PDF, en anglais seulement)

COVID-19 Vaccine: Allergy Assessment and Referral (PDF, en anglais seulement)

Employee Under Investigation and Case Summary Template (EUICS) Guideline (PDF, en anglais seulement)

Employee Under Investigation and Case Summary Template (EUICS) Guideline (xlsx, en anglais seulement)

Manitoba COVID-19 Vaccine: Clinical Practice Guidelines for Immunizers and Health Care Providers (PDF, en anglais seulement)

COVID-19 Vaccine: New/Updated Communications Products including Clinical Practice Guidelines and Consent Form (PDF, en anglais seulement)

IMPORTANT NOTICE: Effective immediately, pause use of AstraZeneca / COVISHIELD in People aged < 55 years (PDF, en anglais seulement)

First Nations Identification for the Purpose of Booking AstraZeneca/ Covishield Vaccination (PDF, en anglais seulement)

Manitoba COVID-19 Vaccine: Updated AstraZeneca and COVISHIELD Product Monographs and Health Product Risk Communication(PDF, en anglais seulement)

Health Product Risk Communication: Important Safety Information on AstraZeneca and COVISHIELD Vaccines(PDF, en anglais seulement)

COVID-19 Vaccine: New/Updated Communications Products including Clinical Practice Guidelines and Consent Form(PDF, en anglais seulement)

COVID-19 Vaccine: Guidance for Immunizers to Select the Reason for Immunization (PDF, en anglais seulement)

janvier 2021 - Memo to Health Care Providers on Enhanced Consent (PDF, en anglais seulement)

Pfizer BioNTech - en anglais seulement

CanVax: COVID-19 Vaccine Questions and Answers for Healthcare Providers en anglais seulement

décembre 2020 - Note aux travailleurs de la santé (PDF, en anglais seulement)